MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study
Article in The Lancet Oncology (April 2024)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
Article in The Lancet Oncology (April 2024)
Article in Frontiers in Cell and Developmental Biology (January 2024)
Article in Cancers (October 2023)